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OBJECTIVE—The effect of glycemic variability (GV) on cardiovascular risk has not been fully
clariﬁed in type 2 diabetes. We evaluated the effect of GV, blood pressure (BP), and oxidative
stress on intima-media thickness (IMT), left ventricular mass index (LVMI), ﬂow-mediated di-
lation (FMD), and sympathovagal balance (low frequency [LF]/high frequency [HF] ratio) in 26
type 2 diabetic patients (diabetes duration 4.41 6 4.81 years; HbA1c 6.70 6 1.25%) receiving
diet and/or metformin treatment, with no hypotensive treatment or complications.
RESEARCH DESIGN AND METHODS—Continuous glucose monitoring (CGM) data
were used to calculate mean amplitude of glycemic excursion (MAGE), continuous overall net
glycemic action (CONGA)-2, mean blood glucose (MBG), mean postprandial glucose excursion
(MPPGE), and incremental area under the curve (IAUC). Blood pressure (BP), circadian rhythm,
and urinary 15-F2t-isoprostane (8-iso-prostaglandin F2a [PGF2a]) were also evaluated. Subjects
were divided into dipper (D) and nondipper (ND) groups according to DBP.
RESULTS—IMTandLVMIwereincreasedinNDversusD(0.7760.08vs.0.6860.13[P=0.04]
and 67 6 14 vs. 55 6 11 [P = 0.03], respectively). MBG, MAGE, and IAUC were signiﬁcantly
associated with LF/HF ratio at night (r =0 . 5 0 ,P =0 . 0 1 ;r =0 . 4 0 ,P =0 . 0 4 ;r =0 . 4 1 ,P =0 . 0 4 ,
respectively),MPPGEwasnegativelyassociatedwithFMD(r=20.45,P=0.02) ,an dCON GA-2was
positivelyassociatedwithLVMI(r=0.55,P=0.006).TheDsystolicBPwasnegativelyassociatedwith
IMT (r=20.43, P=0. 0 3)a n dw i t hL V MI( r=20.52,P= 0.01). Urinary 8-iso-PGF2a waspositively
associated with LVMI (r =0 . 6 8P , 0.001).
CONCLUSIONS—An impaired GV and BP variability is associated with endothelial and
cardiovasculardamage inshort-term diabeticpatientswith optimalmetaboliccontrol.Oxidative
stress is the only independent predictor of increased LV mass and correlates with glucose and BP
variability.
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T
he role of hyperglycemia in the
pathogenesis of micro- and macro-
vascular complicationsiswellknown
(1). However, glycemic variability (GV)
may be important in the development of
chronic diabetes complications, beyond
the average blood glucose (BG) concentra-
tion (2). This issue has not been fully
clariﬁed, because no gold standard mea-
sure of GV is currently available, and
HbA1c, which is an undisputable index of
overall glycemic control, only partially de-
picts glycemic excursions, in particular,
postprandial spikes.
A recent systematic review of the effect
of GV on the development of diabetes
complications suggested a correlation in
type 2 diabetes but not in type 1 (3). The
SanLuigiGonzagaDiabetesStudysupports
the theory of a predictive role of glucose
spikes on the development of cardiovascu-
lar events, showing that BG levels after
lunchbetterpredicttheoccurrenceofcardio-
vasculareventsthanfastingBGand conﬁrm-
ingpreviousobservationsthatpostprandial
hyperglycemia—but not fasting BG—is an
independent risk factor for cardiovascular
disease (4).
Itisstillunclearwhetherpostprandial
glucose excursions, rather than chronic
hyperglycemia, are responsible for the
activation of oxidative stress pathways
and contribute to the development of
cardiovascular disease (5,6). Although
the inﬂuence of a sustained increase in
blood pressure (BP) on cardiovascular
disease is well known, less data are avail-
able on the role of altered circadian
rhythm of BP. The aim of our study was
to investigate the relative role of overall
glycemicload,GV,abnormalBPcircadian
rhythm,andoxidativestressactivationon
organ damage in short-term, well con-
trolled type 2 diabetic patients without
overt complications.
RESEARCH DESIGN AND
METHODS—The study recruited 26
consecutive type 2 diabetic subjects (11
men, 15 women) from the Department of
Endocrinology and Diabetes, S. Giovanni
Calibita Fatebenefratelli Hospital of
Rome, who were being treated with diet
and/or metformin. Informed consent was
obtained from all participants. Exclusion
criteria were diabetic autonomic neuropa-
thy, micro- or macroalbuminuria, prolifer-
ative retinopathy,history ofcardiovascular
events, hypotensive treatment, or neoplas-
tic, immunologic, or other diseases that
were able to modify glucose metabolism.
All study investigations were performed in
accordance with the principles of the
Declaration of Helsinki, and the protocol
was approved by the hospital ethics com-
mittee.
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Pathophysiology/Complications
ORIGINAL ARTICLEStudy design
On the ﬁrst day, all patients underwent a
generalmedicalexamination,andanthro-
pometric parameters and cardiovascular
autonomic neuropathy from Ewing tests
were evaluated. Blood and urine samples
were obtained for the determination of
the albumin excretion rate (AER) and
levels of cholesterol, triglycerides, and
HbA1c.Afteranovernightfast,allsubjects
simultaneously underwent 24-h continu-
ous glucose monitoring (CGM) with the
CGM Minimed System (CGMS; Med-
tronic, Northridge, CA), ambulatory BP
monitoring (ABPM; TM2430, Intermed,
Milan; Italy), and electrocardiogram
monitoring (Aria Holter System, Del
Mar Reynolds Medical, Hertford, U.K.,
and Irvine, CA). The application of the
subcutaneous sensor for the CGMS was
performedapproximately2hbeforestart-
ing BP and electrocardiogram (ECG)
monitoring to calibrate the instrument.
The FreeStyle Lite (Abbott Laboratories,
Abbott Park, IL) BG-monitoring system
was used to calibrate the CGMS. Com-
Station, which allowed us to download
monitor data of glycemia into speciﬁed
ﬁleswhiledataprocessingwasperformed
using CGMS 3.0C Solutions Software
(Minimed, Medtronic). ABPM was mon-
itored by the noninvasive oscillometric
technique (TM2430, Intermed), vali-
dated by the British Hypertension Soci-
ety (7).
A spectral analysis of Holter tapes
(Impresario 2.8, Del Mar Reynolds Med-
ical) was obtained from the ECG monitor-
ingsystem.Frequencydomainmeasuresof
heartratevariabilitywereanalyzedinaccor-
dancewithEuropeanSocietyofCardiology/
North American Society of Pacing and
Electrophysiology recommendations (8).
Each patient collected a 24-h urine sam-
ple until analysis for 15-F2t-isoprostane
(or 8-iso-prostaglandin F2a [PGF2a]) and
creatinine. On the second day, measure-
ments of carotid intima–media thickness
(IMT),leftventricularmass,andendothe-
lial function, studied with ﬂow-mediated
dilation (FMD), were performed.
Assessment of GV indexes
The intraday GV indexes were mean ampli-
tude of glycemic excursions (MAGE), de-
ﬁned as the average of all blood glucose
excursions of more than 1 SD of the 24-h
mean blood glucose value (9), and continu-
ousoverallnetglycemicaction(CONGA-2),
deﬁnedastheSDof the differencesbetween
the current observation and the previous
2-h observation (10).
To assess postprandial glucose excur-
sions from the CGM data, the mean post-
prandial glucose excursions (MPPGEs) of
lunch and dinner and the average were
calculated as the arithmetic mean of the
differences between the postprandial
peak glucose values and the correspond-
ing preprandial glucose values for lunch
and dinner. The incremental area under
the curve (IAUC) after lunch and dinner
and the average were also calculated.
The overall glycemic load was evalu-
ated by HbA1c and by mean BG value
(MBG), calculated as the arithmetic
mean of 24-h glucose values from the
CGM data.
Assessment of blood pressure indexes
The percentage change from day to night
(D) for systolic BP (SBP) and diastolic BP
(DBP) was deﬁned as {[(mean value dur-
ing the day 2 mean value at night) 3
100]/mean value during the day}. A DBP
of less than 10% indicated a nondipper
(ND) BP proﬁle (11).
Assessment of sympathovagal
balance
Fourier transformation was used to trans-
form ﬂuctuations in RR interval widths
into a frequency waveform that depicted
periodic oscillations in sympathetic and
parasympathetic function. The frequency
domain variables, including total power
(0.01–0.40 Hz), high-frequency (HF;
0.15–0.40 Hz), low-frequency (LF;
0.04–0.15 Hz) power, and the HF/LF ra-
tio of day, night, and 24 h, were calcu-
lated, which served as a reliable index of
the sympathovagal balance.
Assessment of endothelial function
and cardiovascular surrogates
Carotid IMT was obtained by B-mode
ultrasound examination (MyLab30,
Esaote, Italy). For each subject, the max-
imal carotid IMT was imaged for the near
and far wall of each common carotid
artery, according to the protocol for mea-
suring carotid IMT used in the Asymp-
tomatic Carotid Artery Plaque Study
(ACAPS) (12).
Echocardiographic examination was
performed with a Vivid 7 system (GE
Healthcare, Milwaukee, WI).Left ventric-
ular mass (LVM) by 2-dimensional imag-
ing was studied and normalized to body
surface area as the LVM index (LVMI).
Recordingsweredigitallystoredand eval-
uatedoff-line(EchoPacstation)according
to the guidelines of the American Society
of Echocardiography (13).
Endothelial function was evaluated
using the FMD of the brachial artery
according to guidelines of the Interna-
tional Brachial Artery Reactivity Task
Force (14).
All examinations were performed by
using an ultrasound system (ACUSON
Sequoia C512 System; Siemens, Erlangen,
Germany) with a broadband 8–14-MHz
transducer. In our laboratory, the coefﬁ-
cient of variation for FMD repeated meas-
urements is 15%. Because of circadian
variations of peripheral vascular tone, the
FMD investigation was performed on all
patients between 8:00 A.M. and 9:00 A.M.
in a quiet, temperature–controlled room
(22–24°C). All subjects were studied after
an overnight fast. Arterial diameterwas de-
termined as the internal dimension of the
vessel wall from the anterior-to-posterior
interface between the lumen and the in-
tima. The mean diameter was calculated
from three measurements of arterial diam-
eter performed at end-diastole with the
R wave on a continuously recorded ECG.
The response of the vessel diameter to re-
active hyperemia was expressed as a per-
centage change relative to the diameter
before cuff inﬂation.
Laboratory measurements
Measurements of 8-iso-PGF2a and cre-
atinine were accomplished using an
enzyme-linked immunosorbent assay
(ELISA) method (Cayman Chemical Co,
Ann Arbor, MI) without extraction in the
u r i n es a m p l eb e f o r ei m m u n o e n z y m a t i c
assay. The normal reference unit used in
thisstudywas1.02–1.3ng/mgcreatinine.
T h em e a nv a l u e6 SD of 8-iso-PGF2a in
our control group ofnormal healthy indi-
viduals was 1.18 6 0.50 ng/mg creati-
nine.
HbA1cwasanalyzedbyhigh-performance
liquid chromatography (VARIANT 2; Bio-
Rad Laboratories, Munich, Germany), with
intra-andinterassaycoefﬁcientsofvariation
of 0.46 to 0.77 and 0.69–0.91%, respec-
tively. Total cholesterol, HDL cholesterol,
and triglycerides were determined by the
Cobas enzymatic colorimetric test (Roche
D i a g n o s t i c ,I n d i a n a p o l i s ,I N ) .A E Rw a sd e -
termined by the Tina-quant immunoturbi-
metric assay (Cobas; Roche Diagnostic).
Urine samples were collected simulta-
neously with CGM, ABPM, and ECG mon-
itoring and stored at 220°C until analysis.
Statistical analysis
Descriptive statistics were reported as the
mean and SD for normally distributed
continuous variables or median with a
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GV and cardiovascular complications25th–75th interquartile range (IQR) for
skewed distribution. Normality of distri-
bution was tested by calculating skew and
kurtosis values. Continuous variables
were compared by the Student t test for
independent samples, and skewed distri-
butions were compared using the Mann–
Whitney U test. Univariate analysis was
done byusinglinearregressionand byde-
termining the Pearson correlation coefﬁ-
cient (r). Multivariate regression analysis
was used toassessindependentpredictors
of cardiovascular diabetes complications,
and adjustment for age was done. Corre-
lation analysis was performed to investi-
gatetherelationshipbetween8-iso-PGF2a
and glycemic and BP control parameters.
AtestresultwithP,0.05wasconsidered
statistically signiﬁcant. For statistical anal-
ysis,Stata/SE11.0software(StataCorpLP,
College Station, TX) was used.
RESULTS—Clinical and laboratory
characteristics of the study population
are reported in Table 1. Other values in-
cluded FMD, 15 6 7 % ;I M T ,0 . 76 0.1
mm; LF/HF day, 2.8 6 1.9; LF/HF night,
2.2 6 1.9; and LVMI, 61.3 6 13.8 g/m
2.
The DSBP (%) was used to divide all
subjects into two groups: dipper (D,
17.5 6 4.3%) and ND (5.9 6 2.4%).
No differences were found between the
two groups in general characteristics and
in 24-h mean SBP and DBP. The ND and
D groups were signiﬁcantly different in
IMT (0.77 6 0.08 vs. 0.68 6 0.13 mm,
P = 0.04) and LVMI (67 6 14 vs. 55 6 11
g/m
2, P = 0.03).
Univariate analysis
The association of all GV indexes with
cardiovascular parameters was tested by
univariate regression analysis. A signiﬁ-
cant association with LF/HF night was
found for MBG (r = 0.50, P = 0.01), 24-h
MAGE (r = 0.40, P = 0.04), and dinner
IAUC (r = 0.41, P = 0.04). MPPGE lunch
was negatively associated with FMD (r =
20.45, P = 0.02). CONGA-2 was posi-
tively associated with LVMI (r =0 . 5 5 ,
P = 0.006). However, no association was
observed between HbA1c or MBG (r =
20.01, P = 0.94) and LVMI (r = 0.37,
P = 0.06). DSBP and DDBP were nega-
tively associated with IMT (r = 20.43,
P = 0.03; r = 20.51, P = 0.009, respec-
tively), and DSBP was negatively associ-
ated with LVMI (r = 20.52, P = 0.01).
Finally, a positive association was found
between8-iso-PGF2aandLVMI(r=0.68,
P , 0.001).
Multivariate analysis
Because our data showed a signiﬁcant
effectofGVandBPvariabilityindexesand
oxidativestressonLVM,theindependent
effects of age, CONGA-2, DSBP, and
8-iso-PGF2a on LVMI were assessed by
multivariate analysis. The only indepen-
dent predictor of increased LVMI was
8-iso-PGF2a (Table 2).
Relationship between 8-iso-PGF2a
and glycemic and BP indexes
We found a positive correlation between
8-iso-PGF2a and CONGA-2 (r =0.57, P =
0.003),MPPGElunch(r=0.52,P=0.008),
and average IAUC (r =0 . 4 6 ,P =0 . 0 2 ) ,a s
well as a negative correlation with DSBP
(r = 20.46, P =0 . 0 2 )a n dDDBP (r =
20.43, P = 0.03).
CONCLUSIONS—The main ﬁnding
of this study is the effect of GV, abnormal
circadian BP rhythm, and oxidative stress
activation on LVMI. An increased LVMI
has already been shown in ND patients
with essential hypertension (15) and in
type 2 diabetic patients with autonomic
neuropathy (16). We now demonstrate
that the effects of an ND pattern on car-
diac mass are already detectable in pa-
tients with normal mean BP values and
with an LVMI within the normal range.
Few and inconsistent data are available
on the role of glycemic control on LVMI
(17),althoughseveralstudieshaveshown
that deteriorating glucose tolerance is as-
sociated with increased LVM. The patho-
physiologic mechanisms underlying this
association are still controversial (18).
It is noteworthy that only GV was
associated with LVMI in our study, and
no association was observed between
HbA1c and LVMI, in agreement with
other reports (19).
To our knowledge, this is the ﬁrst re-
portofacorrelationbetweenGVandorgan
damage in well controlled, uncomplicated
type 2 diabetic patients. We demonstrate
that GV evaluated as CONGA-2—but not
overall glycemic load—has a deleterious
effect on LVMI in well controlled type
2 diabetic patients. The observation that
only CONGA-2, among all parameters of
GV, was signiﬁcantly associated with in-
creasedLVMIispossiblyattributedtothe
metabolic characteristics of our patients.
CONGA-2 is known to detect small glyce-
mic swings, occurring over short intervals
(20),thusappropriatelydescribingthegly-
cemic ﬂuctuations of patients in optimal
metabolic balance, without “peaks and val-
leys” related to hypoglycemic treatment,
because all of our patients were being
treated with diet orby diet and metformin.
Thus, our data suggest that such rapid and
small glycemic excursions seem to be in-
volved in the development of early cardio-
vascular damage in type 2 diabetic patients
with short-term disease and optimal glyce-
mic control.
The pathophysiologic mechanism re-
sponsible for this association could be
represented by the activation of the oxi-
dative stress pathway. In agreement with
this hypothesis, we found a positive asso-
ciation between LVMI and 8-iso-PGF2a,a
Table 1—General characteristics of all
subjects
Variable Mean 6 SD
Age (years) 59.2 6 10.6
Diabetes duration (years) 4.4 6 4.8
BMI (kg/m
2) 26.9 6 3.6
AER (mg/g creatinine) 7.1 6 7.6
Cholesterol
Total (mmol/L) 5.2 6 0.9
HDL (mmol/L) 1.3 6 0.3
Triglycerides (mmol/L) 1.4 6 0.5
8-iso-PGF2a (ng/mg creatinine) 1.8 6 0.8
FBG (mmol/L) 7.1 6 1.6
HbA1c (%) 6.7 6 1.3
MBG (mmol/L) 7.2 6 1.6
MAGE (mmol/mol) 3.2 6 1.7
CONGA-2 (mmol/mol) 1.8 6 0.6
MPPGE (mmol/mol) 1.5 6 2.1
Avg IAUC (mmol/L/h) 483 6 111
DSBP (%) 11.7 6 6.8
DDBP (%) 12.8 6 7.8
Table 2—Multivariate analysis of independent effects on LVMI
Variable Coefﬁcient 95% CI rP
Age 0.22 20.20 to 0.64 0.17 0.286
CONGA-2 0.24 20.14 to 0.63 0.18 0.199
DSBP 0.41 21.14 to 0.31 20.19 0.250
8-iso-PGF2a 6.83 0.69–12.96 0.42 0.031
R
2 = 0.573.
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Di Flaviani and Associatesreliable marker of oxidative stress. More-
over, multivariate analysis showed that
8-iso-PGF2a appeared to be the only inde-
pendent predictor of increased LVMI. We
also observed a signiﬁcant correlation be-
tween 8-iso-PGF2a a n dG Va sw e l la sa b -
normalcircadian BPrhythm.Therefore, an
increased activation of oxidative stress
might represent the common pathogenetic
mechanism, linking GV and abnormal
circadian BP rhythm with an increased
LVMI.
Our study conﬁrms an association
between the ND proﬁle of BP and in-
creased IMT, whereas no association was
observed between IMT and GV or overall
glycemic load. The apparent contradic-
tion between our data and one report of a
correlation between postprandial hyper-
glycemia and IMT (21) may be explained
by the suboptimal metabolic control of
the studied population, which does not
allow the role of GV to be discriminated
fromthatofhyperglycemiaperse.Incon-
trast,ourpatientswereinoptimalmetabolic
control and our results are consistent with
t h er e p o r tb yK a r r e ie ta l .( 2 2 ) ,w h od i dn o t
ﬁnd a correlation in type 2 diabetic patients
with fair glycemic control between carotid
IMT and glucose ﬂuctuations measured by
serum 1,5-anhydroglucitol.
We also found a negative correlation
between postprandial hyperglycemia and
endothelial function, in agreement with
Shige et al. (23), thereby establishing
postprandial hyperglycemia as a determi-
nant of reduced ﬂow-mediated vasodila-
tion in type 2 diabetes. These effects of
postprandial hyperglycemia on endothe-
lial function are probably linked tooxida-
tive stress activation, as suggested by the
positive signiﬁcant correlation between
postprandial hyperglycemia, measured
as MPPGE and IAUC, and urinary iso-
prostanes. However, no correlation was
found with overall glucose load, different
fromwhat wasobservedbyMonnieret al.
(5);again, thisdiscrepancy was attributed
tothealmostnormalbloodglucosevalues
of our patients.
Finally, 24-h GV, postprandial hyper-
glycemia, and MBG signiﬁcantly affect
LF/HF night.Althougharelativeprevalence
of sympathetic over parasympathetic activ-
ity has been reported in insulin-resistant
states,evenintheabsenceofdiabetes(24),
no data are available on the possible effect
of GV on sympathetic activity. We now
demonstrate that GV chronically affects
sympathovagal balance in well controlled
diabetic patients without overt autonomic
neuropathy.Wealsoconﬁrmtheinﬂuence
of postprandial hyperglycemia on sym-
pathovagal activation, as described pre-
viously (25). However, the signiﬁcant
association between MBG and LF/HF, in
t h ep r e s e n c eo fa l m o s tn o r m a la v e r a g e
blood glucose levels, underlines the role
of overall glycemic load, even in the ab-
sence of sustained hyperglycemia, on au-
tonomic balance.
In conclusion, we demonstrate that
an impaired GV and BP variability is
associated with endothelial dysfunction
and increased cardiac mass in diabetic
patients with short-term disease and op-
timal metabolic control. The activation of
oxidative stress is associated with in-
creased LVM and variability of glucose
levels and BP. Intervention studies are
needed to investigate the beneﬁts of the
correction of glucose ﬂuctuations on car-
diovascular parameters, and to address
the issue of treatment choices, in diabetic
patients.
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